CK Life Sciences International Holdings (HKSE:00775) EBIT per Share : HK$0.04 (TTM As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

What is CK Life Sciences International Holdings EBIT per Share?

CK Life Sciences International Holdings's EBIT per Share for the six months ended in Dec. 2023 was HK$0.02. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.04.

During the past 12 months, the average EBIT per Share Growth Rate of CK Life Sciences International Holdings was -8.00% per year. During the past 3 years, the average EBIT per Share Growth Rate was 36.70% per year. During the past 5 years, the average EBIT per Share Growth Rate was -6.10% per year. During the past 10 years, the average EBIT per Share Growth Rate was -4.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for CK Life Sciences International Holdings's EBIT per Share or its related term are showing as below:

HKSE:00775' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -32.7 Med: -4.5 Max: 116.5
Current: 36.7

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of CK Life Sciences International Holdings was 116.50% per year. The lowest was -32.70% per year. And the median was -4.50% per year.

HKSE:00775's 3-Year EBIT Growth Rate is ranked better than
85.81% of 1311 companies
in the Biotechnology industry
Industry Median: 3.7 vs HKSE:00775: 36.70

CK Life Sciences International Holdings's EBIT for the six months ended in Dec. 2023 was HK$192 Mil.

CK Life Sciences International Holdings EBIT per Share Historical Data

The historical data trend for CK Life Sciences International Holdings's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CK Life Sciences International Holdings EBIT per Share Chart

CK Life Sciences International Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

0.04

0.03

0.04

CK Life Sciences International Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBIT per Share	Get a 7-Day Free Trial															0.02	0.02	0.02	0.02	0.02

CK Life Sciences International Holdings EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

CK Life Sciences International Holdings's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	391.009	/	9611.073
=	0.04

CK Life Sciences International Holdings's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	192.472	/	9611.073
=	0.02

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.04

CK Life Sciences International Holdings (HKSE:00775) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

CK Life Sciences International Holdings EBIT per Share Related Terms

Thank you for viewing the detailed overview of CK Life Sciences International Holdings's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

CK Life Sciences International Holdings (HKSE:00775) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CK Life Sciences International Holdings Inc (HKSE:00775) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

LSI:Germany

Address

2 Dai Fu Street, Tai Po Industrial Estate, Tai Po, Hong Kong, HKG

Website

https://www.ck-lifesciences.com

CK Life Sciences International Holdings Inc is a biotechnology company engaged in the research & development, commercialization, and sale of health and agricultural-related products. Products developed by CK Life Sciences are categorized into the areas of human health and environmental sustainability. The company operates three core businesses, including agriculture, nutraceutical, and pharmaceutical. Its overall product portfolio involves a presence that spans North America and the Asia Pacific. The company uses mergers and acquisitions when it identifies attractive market opportunities.

CK Life Sciences International Holdings (HKSE:00775) Headlines

No Headlines